Compare STOK & CHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STOK | CHCO |
|---|---|---|
| Founded | 2014 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2019 | 1995 |
| Metric | STOK | CHCO |
|---|---|---|
| Price | $36.13 | $119.90 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 2 |
| Target Price | $36.10 | ★ $132.50 |
| AVG Volume (30 Days) | ★ 560.9K | 69.4K |
| Earning Date | 04-15-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.83% |
| EPS Growth | ★ 30.67 | 13.18 |
| EPS | 0.85 | ★ 8.93 |
| Revenue | ★ $36,555,000.00 | N/A |
| Revenue This Year | $430.19 | $5.16 |
| Revenue Next Year | N/A | $3.12 |
| P/E Ratio | $42.08 | ★ $13.80 |
| Revenue Growth | ★ 316.34 | N/A |
| 52 Week Low | $5.35 | $102.22 |
| 52 Week High | $38.62 | $133.59 |
| Indicator | STOK | CHCO |
|---|---|---|
| Relative Strength Index (RSI) | 64.73 | 36.28 |
| Support Level | $30.50 | $117.09 |
| Resistance Level | $37.98 | $123.70 |
| Average True Range (ATR) | 2.04 | 3.27 |
| MACD | 0.41 | -0.67 |
| Stochastic Oscillator | 77.87 | 9.93 |
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.